This section is dedicated to the E-Rare and all important events related to the research on rare diseases. It is being updated on a weekly basis.

Keystone Symposia on "Rare and Undiagnosed Diseases: Discovery and Models of Precision Therapy"

Keystone Symposia on "Rare and Undiagnosed Diseases: Discovery and Models of Precision Therapy"
Sunday, March 5, 2017

The Keystone Symposia’s on “Rare and Undiagnosed Diseases: Discovery and Models of Precision Therapy” will be held in Boston, Massachusetts, USA on March 5-8, 2017.

Organized by Drs. William A. Gahl of the National Human Genome Research Institute at NIH and Christoph Klein of Ludwig-Maximilians-University Munich, the three-day open conference is for research scientists, clinicians and advocacy groups alike and will cover approaches and best practices in researching rare and undiagnosed disorders, ways to break down data sharing barriers to facilitate new disease discovery, and examples of successful descriptions of new diseases, mechanisms, and treatments.

Of the 7000 known rare diseases, only a fraction have their molecular and mechanistic bases delineated, and many other diseases have yet to be discovered. Characterization of these disorders will reveal new biochemical pathways and cell biological processes, point to potential drug targets, and provide hope for millions of affected individuals.
This meeting will address approaches and best practices in pursuing rare and undiagnosed disorders, limitations in data sharing as a barrier to new disease discovery, and examples of successful descriptions of new diseases, mechanisms, and treatments. Specific aims include fostering the development of expertise in rare diseases and the definition of their natural histories; an international network of scientists and physicians collaborating on new disease discovery by sharing phenotypic and sequence data; and new therapeutic approaches based upon rare and new disease mechanisms.
Through this meeting, participants should become familiar with rare and undiagnosed disease programs, acquire insights into new disease mechanisms, learn about potential therapeutic targets, and establish collaborations that enhance rare disorder expertise and new disease discovery. The meeting will bring together physicians who are expert in rare disorders with scientists who know metabolic pathways and mechanisms, advancing understanding and therapy. A desired outcome of the meeting includes developing lists of clinical and basic research experts for synergistic collaborations, and creating an international organization to perpetuate the joint investigation of rare and new diseases.

You can find more information about the program and speakers on the Keystone Symposia’s website.

E-Rare 2012 - Created by Toussaint Biger